BACKGROUND Nondepolarizing muscle relaxants (NDMRs) used in current clinical practice have slower onset of action and are not suitable for rapid control of airway. In order to reduce interval between the administration of NDMRs to optimal intubating conditions, administering priming dose, a sub-paralysing dose of the NDMRs, few minutes before giving a large calculated dose is recommended for smooth tracheal intubation. Cisatracurium Besylate, an agent with 4 times potency of Atracurium, has a longer onset time. We wanted to compare two different priming doses of Cisatracurium with a bolus administration to arrive at an optimal priming dose of Cisatracurium. METHODS In this prospective randomised double-blind study, we evaluated the effect of two different priming regimens (10 and 15 microgram/Kg) from the total 100 mcg/Kg of Cisatracurium with regard to onset time of intubation as assessed by TOF (Train of Four) disappearance time compared to a bolus administration. 90 patients scheduled for various elective abdominal surgeries under general anaesthesia with endotracheal intubation, were enrolled and were divided into 2 study groups and 1 control group. Systolic and diastolic blood pressures, mean arterial pressure, heart rate, oxygen saturation and capnography were assessed before administration of study drug, before intubation, and subsequently, immediately after intubation and at 1, 3 and 10 minutes after intubation. Also, TOF disappearance time by acceleromyograph, intubation score by Viby Mogensen and adverse effects related to priming were assessed. RESULTS TOF disappearance time was shorter (148.07±12.63 second) in the group with priming dose of 15 mcg/Kg Cisatracurium than in the group with priming dose of 10 mcg/Kg (177.13±9.54). TOF disappearance time was longer (211.70±25.97) in the group where no priming drug but only the bolus dose was used for intubation. There were no statistically significant differences in intubation scores, haemodynamic parameters among all three groups in all time intervals. No adverse effects were found in any groups. CONCLUSIONS Priming dose of Cisatracurium reduces the onset time for intubation without affecting intubating conditions and haemodynamic parameters. Reduction in the onset time for intubation is more with higher priming doses (15%) than with lower priming dose (10%).